Skip to content

CorKid (COVID19/ SARS-CoV-2 seroconversion in kids)

CorKid (COVID19/ SARS-CoV-2 seroconversion in kids) - CorKid

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022434
Enrollment
3000
Registered
2020-08-07
Start date
2020-06-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Children and adolescents attending for a medical check-up in selected pediatric practices receive a questionnaire on e.g. risk of infection and clinical symptoms in the last 3 months. Then t

Sponsors

Universitätskinderklinik im St.-Josef Hospital Klinikum der Ruhr-Universität-Bochum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 18 Years

Inclusion criteria

Inclusion criteria: - 6 months– 18 years - Patients who present in the practice for routine medical screening (U-Untersuchungen) - signed consent - Mothers or other family members (fathers, siblings) of the subjects primarily included (of all ages from 6 months)

Exclusion criteria

Exclusion criteria: no consent to the study

Design outcomes

Primary

MeasureTime frame
In children and adolescents, seroconversion rate for SARS-CoV-2 will be detectable in 10-20% within the observation period of 6 months

Secondary

MeasureTime frame
In children and adolescents, there are risk factors such as certain polymorphisms in the ACE2 receptor or pulmonary pre-existing conditions for more severe courses of a COVID-19 infections.

Countries

Germany

Contacts

Public ContactCorkid Studienteam

Universitätskinderklinik Bochum

corkid@klinikum-bochum.de0234/ 509 6673

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026